November 11th 2024
AHA 2024. Study authors reported a 74% lower risk of death and an 84% lower risk of MI among participants taking either a GLP-1RA or an SGLT2i.
Elevating Care for PAH: Applying Recommended Management Approaches to Maximize Outcomes
View More
7th Annual New York Cardio-Endo-Renal Collaborative (NY CERC)
View More
‘REEL’ Time Patient Counseling™: Navigating the Complex Journey of Diagnosing and Managing Fabry Disease
View More
Expert Illustrations & Commentaries™: Envisioning Novel Therapeutic Approaches to Managing ANCA-associated Vasculitis
View More
Surv.AI Says: Real-World Insights Into the Journey for Patients With Pulmonary Arterial Hypertension
View More
Cases and Conversations: Evidence-Based Approaches to Management of CKD in Your Patients With T2DM
View More
Raising Our Game in the Management of Hyperlipidemia: New Targets, New Tactics
View More
Highly Processed Food is Produced to Be as Rewarding as Humanly Possible, Says Food Addiction Expert
February 20th 2023Foods that are "engineered" with refined carbohydrates and fats that are rapidly absorbed can lead to cravings on par with those for alcohol and nicotine, says Ashley Gearhardt, PhD.
Cardiometabolic Diseases and Dementia Risk Show Dose-dependent Relationship in Large Twin Study
January 13th 2023For each cardiometabolic disease, the risk of all-cause dementia rose by 42%; the risk rose 26% for Alzheimer disease and 64% for vascular dementia. Temporal onset and genetics play key roles.